Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Bioquest Corp

BQST SEC CIK 1568628
Follow Bioquest Weekly email: filings, results, news

Financials

Reported figures only · latest: fiscal 2022 USD · US GAAP
Net income −$821K +64.7% vs prior year
EPS, diluted −$0.08 +11.1% vs prior year
Operating cash flow −$116.7K +39.6% vs prior year
Operating income −$817.9K +62.8% vs prior year
Revenue by fiscal year
$0
$0
FY13 FY14

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$3M−$2M−$1M$0FY12FY13FY14FY19FY20FY21FY22
Show the numbers
YearNet income
FY22−$821K
FY21−$2.3M
FY20−$359K
FY19-
FY14−$488K
FY13−$8.3K
FY12-

News

No stories filed under Bioquest yet - coverage appears here as the news feed clusters it.